Ultimovacs
Menu Close ✕
  • About
    • About Ultimovacs
    • Team
    • Board of directors
  • Technology
    • Technology overview
    • Immunotherapy
    • Clinical studies
  • Investors
    • Shares
    • Reports and presentations
    • Investor relations contacts
    • Analyst coverage
    • Governance
    • News
  • Contact
Ultimovacs  –  News  –  QuickView company update on Ultimovacs has been published by Edison Investment Research (company sponsored research)

QuickView company update on Ultimovacs has been published by Edison Investment Research (company sponsored research)

Ultimovacs – Phase II data from 500+ patients over 2022/23

 

Print this article
20, January, 2021
E-mail: mail@ultimovacs.com
Phone number: +47 413 80 080
Ullernchausséen 64
0379 Oslo
Norway
View in Google Maps

Technology

  • Technology
  • Clinical studies
  • Immunotherapy

Ultimovacs

  • About Ultimovacs
  • Team
  • Board of directors
  • Contact us

Investors

  • Share information
  • Financial reports
  • Investor relations contacts
  • News
Copyright © Ultimovacs ASA 2021